Macquarie Group LTD Mirati Therapeutics, Inc. Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$41.27 - $98.62 $26,330 - $62,919	-638 Reduced 1.05%	60,000 $2.72 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $24,811 - $36,153	-417 Reduced 0.68%	60,638 $4.26 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $354,123 - $802,204	-9,043 Reduced 12.9%	61,055 $4.1 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $21,836 - $43,479	288 Added 0.41%	70,098 $5.76 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $27,986 - $40,341	212 Added 0.3%	69,810 $10.2 Million

Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $360,054 - $483,551	-2,725 Reduced 3.77%	69,598 $12.3 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $1.36 Million - $1.7 Million	-9,451 Reduced 11.56%	72,323 $11.7 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $1.94 Million - $2.71 Million	-12,234 Reduced 13.01%	81,774 $14 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $4.18 Million - $6.2 Million	-25,787 Reduced 21.53%	94,008 $20.6 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $7.4 Million - $10.9 Million	-65,376 Reduced 35.31%	119,795 $19.9 Million
Q2 2020 Aug 11, 2020	BUY	$72.01 - $120.39 $496,869 - $830,691	6,900 Added 3.87%	185,171 $21.1 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $4.08 Million - $7.43 Million	-57,659 Reduced 24.44%	178,271 $23 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $958,293 - $1.35 Million	12,300 Added 5.5%	235,930 $18.4 Million
Q3 2018 Nov 15, 2018	SELL	$47.1 - $62.7 $70,650 - $94,050	-1,500 Reduced 0.67%	223,630 $10.5 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $39,075 - $78,600	1,500 Added 0.67%	225,130 $11.1 Million
Q1 2018 May 11, 2018	BUY	$17.2 - $34.95 $2.46 Million - $5 Million	143,030 Added 177.46%	223,630 $6.87 Million
Q4 2017 Feb 15, 2018	BUY	$12.65 - $19.0 $7,590 - $11,400	600 Added 0.75%	80,600 $1.47 Million
Q3 2017 Nov 08, 2017	BUY	$4.7 - $11.7 $376,000 - $936,000	80,000	80,000 $936,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account